Solutions ❯ By Industry ❯ Pharmaceutical
Your Distributor Passed Every Review.
Who Owns It Now?
Pharmaceutical Supplier Due Diligence True Pharma Due Diligence Must Go Beyond A Quality Review.
9.3 /10
Average Satisfaction for Ownership/UBO
Average satisfaction among customers using KYB Complete for ownership and UBO verification.
8.3 /10
Overall Average Satisfaction for KYB Complete
Average satisfaction across all KYB Complete survey respondents.
450 M+
Total no. of Searchable Entities
Asian entities searchable across the AsiaVerify platform.
The Corporate Gap 3 Checks Covered. 3 Critical Gaps Remain.
GMP Controls
Assess manufacturing quality and process compliance, not the ownership of the legal entity behind the site.
GxP Controls
Support regulated operating practices and data integrity, rather than confirming who owns or controls the supplier.
Supplier Quality Reviews
Evaluate performance, capability and quality systems without necessarily tracing shareholders or beneficial owners.
Entity Verification
Matches the manufacturer, distributor or service provider in the agreement to an official company record.
Ownership Checks
Reviews available shareholders and ultimate beneficial owners behind the approved company.
Post-Approval Monitoring
Surfaces supported changes to company status, officers or ownership after the relationship begins.
Where Pharma Supplier Risk Sits A Compliant Partner Can Still Hide Corporate Risk
Quality Reviews Stop at Operations
Quality Reviews Stop at Operations
Supplier quality checks assess capability and performance. They do not always verify the owners behind the company.
Distributors Add Another Layer
Distributors Add Another Layer
The contracted distributor may sit between the manufacturer, product owner and ultimate controlling entity.
Ownership Crosses Borders
Ownership Crosses Borders
A partner may operate in one market while shareholders and controlling entities sit in several others.
Ownership Changes After Approval
Ownership Changes After Approval
A distributor can remain operationally compliant while its shareholders, officers or controllers change.
The Trading Name May Mislead
The Trading Name May Mislead
Supplier records may use a brand or local trading name that does not clearly identify the contracted legal entity.
Clean Audits Do Not Clear Ownership
Clean Audits Do Not Clear Ownership
Strong quality results do not answer whether ownership creates sanctions, transparency or control concerns.
Best on the market at unravelling complex ultimate beneficial ownership structures between Hong Kong and mainland China.
Closing Pharma Due Diligence Gap Add Corporate Due Diligence to Existing Quality Controls
Verify the contracted entity
Match the company named in the agreement to an official record and confirm its registration details.
See Sample Report
Review shareholders and UBOs
Identify available shareholders and ultimate beneficial owners behind the approved partner.
See Sample Report
Check sanctions and business risk
Review approved risk information alongside existing quality and regulatory controls.
See Sample Report
Understand control structures
Map available holding companies, shareholders and controllers across supported corporate layers.
See Sample Report
Real-Time Risk Intelligence for Pharmaceutical Networks Know the company behind every approved manufacturer and distributor.
Trusted for Complex Ownership Verification
Customers using KYB Complete for ownership and UBO verification rate it 9.3/10 on average.
Ownership and UBO verification users KYB Complete users
A financial services customer described KYB Complete as best on the market for complex Hong Kong and mainland China ownership structures.
Financial services customer Regulatory compliance team
A legal customer rated KYB Complete 10/10 and cited shareholders, UBO discovery and Directors & Officers as the most-used features.
Legal customer Due diligence team
Verify the Partner Confirm the Legal Entity Behind the Agreement.
Built for Pharma Due Diligence Company and Ownership Intelligence for Pharmaceutical Networks
Compliance & Risk Teams
Stronger Controls, Less Manual Work
Automate Compliance. Strengthen Risk Controls.
Compliance teams face constant regulatory pressure and heavy manual workloads.
AsiaVerify reduces false positives, and keeps you audit-ready with real-time, registry-backed data—so your team can focus on strategy, not spreadsheets.
Manufacturing
Build Resilient Supply Chains With Visibility
Verify Suppliers And Ownership Risks
Reduce operational and reputational risk by validating suppliers, distributors, and joint venture partners across Asia-Pacific.
AsiaVerify uncovers ownership structures, sanctions exposure, and entity changes to support compliant, resilient sourcing decisions.
Procurement Teams
Verify Every Supplier Before You Engage
Source with Confidence, Verify Every Supplier in APAC
In procurement, one unreliable supplier can disrupt operations and damage your reputation.
AsiaVerify helps you instantly confirm supplier legitimacy, uncover hidden ownership risks, so you can build stronger supply chains with confidence.
Mid-Market
Compliance That Scales With Your Growth
Compliance That Scales With You
As your business grows, the scope and complexity of your compliance obligations increase, along with your potential exposure to compliance risk.
AsiaVerify helps mid-market companies verify customers, partners, and vendors in real time, manage regulatory demands across multiple markets.
Go Deeper Pharmaceutical Supplier Due Diligence Resources
Read more about Every Third-Party Risk Process Has a Blind Spot
Every Third-Party Risk Process Has a Blind Spot
Most third party due diligence checks what a supplier does, not who owns it. See where the ownership blind spot hides, and how to close it.
Read more about AsiaVerify Introduces KYB Complete: Closing the Gap in Due Diligence
AsiaVerify Introduces KYB Complete: Closing the Gap in Due Diligence
AsiaVerify launches KYB Complete, delivering six-factor, decision-ready due diligence for China, Singapore, and Hong Kong supply chains.
Read more about Mind the Gap: Why Your Due Diligence Is Incomplete Without Asian Data
Mind the Gap: Why Your Due Diligence Is Incomplete Without Asian Data
Without verified Asian registry data, your global due diligence is incomplete and you are left open to risk.
Strengthen Pharmaceutical Supplier Due Diligence Stay Ahead of Regulatory Changes
Get the 2026/27 Regulatory Change Checklist
Close the Ownership Gap Your Quality Programme Is Mature. Ownership Verification May Not Be.
FAQs Pharma Supplier Ownership and Compliance: Frequently Asked Questions
What is pharmaceutical supplier due diligence?
It is the process of verifying the legal entity behind a manufacturer, distributor or service provider, reviewing available ownership information, and assessing corporate risk alongside quality and regulatory controls.
Do GMP and GxP controls cover beneficial ownership?
GMP and GxP controls focus on regulated operating practices and product quality. They are not designed to identify the beneficial owners of the legal company.
Why does distributor ownership matter in pharmaceutical supply chains?
A distributor can remain operationally compliant while shareholders, officers or controlling entities change. Ownership checks add visibility into who ultimately controls the approved company.
How does pharmaceutical due diligence differ from supplier quality review?
Supplier quality review evaluates capability, quality systems and performance. Pharmaceutical due diligence adds legal-entity, ownership and corporate-risk checks.
Can a pharmaceutical supplier change ownership after approval?
Yes. Shareholders, directors and company status can change after onboarding. Supported monitoring can help surface relevant company changes for review.
What should a pharmaceutical due diligence checklist include?
A checklist may include legal-entity verification, registration status, available ownership and UBO information, approved business-risk checks, evidence retention and post-approval review triggers.
How does KYB Complete support pharmaceutical supplier due diligence?
KYB Complete helps teams confirm the legal entity, review available company and ownership information, and assess approved business-risk factors alongside existing quality and procurement controls. Take a peak today.
Which pharmaceutical partners should be verified?
Verification can support manufacturers, distributors, wholesalers, contract organisations, service providers and other third parties where the legal entity or ownership requires confirmation.
How do you verify a pharmaceutical distributor?
Match the contracted name and registration details to official company records, review current status, and assess available shareholders, officers and beneficial owners. Run a free verification check in minutes via our free portal – no credit card required.
Can KYB Complete replace GMP, GxP or supplier quality programmes?
No. KYB Complete adds company, ownership and risk intelligence. Specialist quality, manufacturing and regulatory controls remain separate.
How can pharma procurement teams use ownership data?
Ownership information can support onboarding, escalation, enhanced review and documented decisions for higher-risk or complex pharmaceutical partners.
Can AsiaVerify monitor pharmaceutical supplier changes?
AsiaVerify supports monitoring of company changes across supported markets. Confirm product scope and market coverage for the intended workflow.
What information is available across Asian markets?
Company and ownership data availability varies by jurisdiction, entity type and official-source disclosure. Confirm market and data availability with the team before building a workflow that depends on specific fields or entity types.
Can results be delivered by API?
AsiaVerify supports API delivery for relevant products and workflows. Confirm the required fields and jurisdiction coverage with the team.
How do I get started?
Schedule a 20-minute call to discuss the partner types, jurisdictions and company information required for your due diligence workflow.